Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Antimicrobial Agents and Chemotherapy
|
November 9, 2011
Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system
Arnold Louie, Brian D Vanscoy, Henry S Heine, et al.
Antimicrobial Agents and Chemotherapy
|
September 27, 2017
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an <i>In Vitro</i> Infection Model
Brian D VanScoy, David Tenero, Simon Turner, et al.
Antimicrobial Agents and Chemotherapy
|
September 20, 2021
Gepotidacin Pharmacokinetics-Pharmacodynamics against Escherichia coli in the One-Compartment and Hollow-Fiber <i>In Vitro</i> Infection Model Systems
Brian D VanScoy, Elizabeth A Lakota, Haley Conde, et al.
Antimicrobial Agents and Chemotherapy
|
July 15, 2020
Relationship between Gepotidacin Exposure and Prevention of On-Therapy Resistance Amplification in a Neisseria gonorrhoeae Hollow-Fiber <i>In Vitro</i> Infection Model
Brian D VanScoy, Nicole E Scangarella-Oman, Steven Fikes, et al.
Antimicrobial Agents and Chemotherapy
|
March 14, 2018
Evaluation of Ceftolozane-Tazobactam in Combination with Meropenem against Pseudomonas aeruginosa Sequence Type 175 in a Hollow-Fiber Infection Model
M Montero, Brian D VanScoy, Carla López-Causapé, et al.
Antimicrobial Agents and Chemotherapy
|
July 30, 2014
Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection model
Brian D VanScoy, Rodrigo E Mendes, Mariana Castanheira, et al.
Antimicrobial Agents and Chemotherapy
|
March 22, 2023
Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches
A J Lepak, M Trang, J P Hammel, et al.
Antimicrobial Agents and Chemotherapy
|
February 21, 2019
Apotransferrin in Combination with Ciprofloxacin Slows Bacterial Replication, Prevents Resistance Amplification, and Increases Antimicrobial Regimen Effect
Paul G Ambrose, Brian D VanScoy, Brian M Luna, et al.
Antimicrobial Agents and Chemotherapy
|
July 15, 2020
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Dose Selection for ME1100, an Arbekacin Inhalation Solution
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, et al.
Antimicrobial Agents and Chemotherapy
|
January 21, 2016
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model
Anthony M Nicasio, Brian D VanScoy, Rodrigo E Mendes, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Antimicrobial Agents and Chemotherapy
|
November 9, 2011
Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system
Arnold Louie, Brian D Vanscoy, Henry S Heine, et al.
Antimicrobial Agents and Chemotherapy
|
September 27, 2017
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an <i>In Vitro</i> Infection Model
Brian D VanScoy, David Tenero, Simon Turner, et al.
Antimicrobial Agents and Chemotherapy
|
September 20, 2021
Gepotidacin Pharmacokinetics-Pharmacodynamics against Escherichia coli in the One-Compartment and Hollow-Fiber <i>In Vitro</i> Infection Model Systems
Brian D VanScoy, Elizabeth A Lakota, Haley Conde, et al.
Antimicrobial Agents and Chemotherapy
|
July 15, 2020
Relationship between Gepotidacin Exposure and Prevention of On-Therapy Resistance Amplification in a Neisseria gonorrhoeae Hollow-Fiber <i>In Vitro</i> Infection Model
Brian D VanScoy, Nicole E Scangarella-Oman, Steven Fikes, et al.
Antimicrobial Agents and Chemotherapy
|
March 14, 2018
Evaluation of Ceftolozane-Tazobactam in Combination with Meropenem against Pseudomonas aeruginosa Sequence Type 175 in a Hollow-Fiber Infection Model
M Montero, Brian D VanScoy, Carla López-Causapé, et al.
Antimicrobial Agents and Chemotherapy
|
July 30, 2014
Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection model
Brian D VanScoy, Rodrigo E Mendes, Mariana Castanheira, et al.
Antimicrobial Agents and Chemotherapy
|
March 22, 2023
Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches
A J Lepak, M Trang, J P Hammel, et al.
Antimicrobial Agents and Chemotherapy
|
February 21, 2019
Apotransferrin in Combination with Ciprofloxacin Slows Bacterial Replication, Prevents Resistance Amplification, and Increases Antimicrobial Regimen Effect
Paul G Ambrose, Brian D VanScoy, Brian M Luna, et al.
Antimicrobial Agents and Chemotherapy
|
July 15, 2020
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Dose Selection for ME1100, an Arbekacin Inhalation Solution
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, et al.
Antimicrobial Agents and Chemotherapy
|
January 21, 2016
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model
Anthony M Nicasio, Brian D VanScoy, Rodrigo E Mendes, et al.
Page
of 3